Vitamin D Oral Gel for Prevention of Radiation Induced Oral Mucositis (NCT04308161) | Clinical Trial Compass
UnknownPhase 2
Vitamin D Oral Gel for Prevention of Radiation Induced Oral Mucositis
Egypt45 participantsStarted 2019-11-02
Plain-language summary
The main aim of this study was to evaluate clinically the effect of topical oral vitamin D gel in comparison to conventional therapy in prevention of radiation - induced oral mucositis
Who can participate
Age range25 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who are going to receive radiotherapy as a treatment of head and neck cancer either as postoperative (adjuvant) therapy or definitive therapy.
* Patients whose radiotherapy treatment planned dose is 50 Gy or above.
* Patients receiving radiotherapy alone or receiving concomitant cisplatin (or carboplatin) with radiotherapy.
Exclusion Criteria:
* Patients under Anticoagulants such as warfarin, heparin, or aspirin.
* Patients whose radiotherapy treatment planned dose is lower than 50 Gy.
* Patients suffering from any uncontrolled systemic diseases (such as diabetes, cardiovascular, liver disorder, renal dysfunction)
* Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure.
* Hyper-calcemic patients.
* Smokers.
What they're measuring
1
Changes in severity of oral mucositis at different time points along the study